Immuneering Ownership | Who Owns Immuneering?
Immuneering Ownership Summary
Immuneering is owned by 7.67% institutional investors, 27.81% insiders, and 64.51% retail investors. Citadel advisors is the largest institutional shareholder, holding 6.41% of IMRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.01% of its assets in Immuneering shares.
IMRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Immuneering | 7.67% | 27.81% | 64.51% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Citadel advisors | 1.88M | 6.41% | $2.41M |
| Vanguard group | 1.06M | 3.54% | $2.33M |
| Price t rowe associates inc /md/ | 767.12K | 2.57% | $1.69M |
| Goldman sachs group | 741.55K | 2.52% | $949.18K |
| Blackrock | 533.36K | 1.82% | $682.71K |
| Blackrock funding, inc. /de | 318.76K | 1.07% | $701.28K |
| Two sigma advisers, lp | 248.70K | 0.85% | $318.34K |
| Southport management | 215.00K | 0.72% | $473.00K |
| Geode capital management | 208.39K | 0.70% | $458.60K |
| Rockefeller capital management | 177.38K | 0.59% | $390.23K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Southport management | 215.00K | 1.71% | $473.00K |
| Tidemark | 44.40K | 0.04% | $97.68K |
| Point72 asia (singapore) pte. | 17.42K | 0.01% | $38.33K |
| Xtx topco | 32.65K | 0.01% | $71.83K |
| Corsair capital management | 10.00K | 0.00% | $22.00K |
| Bridgeway capital management | 51.35K | 0.00% | $112.97K |
| Tang capital management | 12.07K | 0.00% | $26.56K |
| Rockefeller capital management | 177.38K | 0.00% | $390.23K |
| Two sigma advisers, lp | 248.70K | 0.00% | $318.34K |
| Citadel advisors | 1.88M | 0.00% | $2.41M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Goldman sachs group | 741.55K | 0.00% | 287.31K |
| Two sigma advisers, lp | 248.70K | 0.00% | 248.70K |
| Rockefeller capital management | 177.38K | 0.00% | 177.38K |
| Susquehanna group, llp | 88.76K | - | 88.76K |
| First manhattan co. llc. | 32.33K | 0.00% | 32.33K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Cormorant asset management, lp | - | - | -3.30M |
| Blackrock | 533.36K | - | -843.76K |
| Renaissance | - | - | -349.10K |
| Highvista strategies | - | - | -254.51K |
| Prosight management, lp | - | - | -190.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Two sigma advisers, lp | 248.70K | 0.00% | 248.70K | $318.34K |
| Rockefeller capital management | 177.38K | 0.00% | 177.38K | $390.23K |
| Tang capital management | 12.07K | 0.00% | 12.07K | $26.56K |
| Vanguard personalized indexing management | 11.71K | 0.00% | 11.71K | $25.75K |
| Russell investments group | 6.59K | - | 6.59K | $8.44K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -4.00 |
| Nisa investment advisors | -10.00 |
| Farther finance advisors | -80.00 |
| Amalgamated bank | -684.00 |
| Advisor group | -1.00K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 23 | -39.47% | 2,290,179 | -47.42% | 7 | 3.60% | 9 | -40.00% | 5 | -70.59% |
| Sep 30, 2024 | 38 | -30.91% | 4,355,311 | -54.58% | 14 | 1.37% | 15 | -58.33% | 17 | - |
| Jun 30, 2024 | 55 | 10.00% | 9,588,469 | -19.23% | 32 | 1.98% | 36 | 80.00% | 17 | -29.17% |
| Mar 31, 2024 | 50 | -3.85% | 11,871,552 | -26.40% | 40 | 1.34% | 20 | -4.76% | 24 | 33.33% |
| Dec 31, 2023 | 52 | -1.89% | 16,130,676 | -4.79% | 55 | 1.58% | 21 | -34.38% | 18 | 63.64% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 722.79K | 2.01% | - |
| T. Rowe Price Health Sciences | 431.83K | 1.20% | -6.52K |
| Vanguard Institutional Extnd Mkt Idx Tr | 289.20K | 0.81% | - |
| TD Health Sciences - I | 75.44K | 0.21% | - |
| NT R2000 Index Fund - NL | 60.79K | 0.20% | -260.00 |
| NT R2000 Growth Index Fund - NL | 52.97K | 0.18% | - |
| NT R2000 Index Fund - DC - NL - 2 | 48.11K | 0.16% | -378.00 |
| Bridgeway Ultra-Small Company Market | 49.85K | 0.16% | 25.00K |
| Range Cancer Therapeutics ETF | 54.84K | 0.15% | - |
| iShares Micro-Cap ETF | 49.51K | 0.14% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 01, 2024 | Cormorant Asset Management, LP | - | Sell | $919.50 |
| Apr 01, 2024 | Cormorant Asset Management, LP | - | Sell | $305.00 |
| Apr 01, 2024 | Cormorant Asset Management, LP | - | Sell | $1.82K |
| Apr 01, 2024 | Cormorant Asset Management, LP | - | Sell | $30.10 |
| Apr 01, 2024 | Cormorant Asset Management, LP | - | Sell | $307.00 |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | 8 |
| 2024 Q1 | 12 | 5 |
| 2023 Q2 | - | - |
IMRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools